Dr. Sushama Jadhav

About

Dr. Sushama Jadhav is a leading molecular biologist with more than 32 years of experience in infectious disease research. She has worked as a Sr. Technical Officer at the Indian Council of Medical Research-National Institute of Translational Virology and AIDS Research (formerly the National AIDS Research Institute). She holds a Ph.D. in Health Sciences from Symbiosis International University and has published over 35 research articles, 5 reviews, and two book chapters in top-tier journals. Dr. Jadhav currently leads the Basic Immunology and Technology Development Department, where she leads a team of research trainees focused on diagnosing multiple pathogens responsible for antimicrobial resistance and developing HIV diagnostics. She has attended national and international conferences and symposiums. She has mainly characterized HIV-1, HIV-2, and host genetic polymorphisms to correlate their association with disease progression. Dr. Jadhav was one of the members of the HPTN052, ACTG 5175 multicentric study and published data in NEJM in 2016, 2011, and Lancet in 2008. She is a member of the International AIDS Society (IAS), Member ID: 40353, Lifetime Membership of the Indian Science Congress Association, Membership No.: L29969, and Global Outreach—Contributing Membership ID: 200317975. Dr. Jadhav is a reviewer for various esteemed journals and has achieved certification for the same. The ORCID link is https://orcid.org/0000-0002-8966-7017.

Employment

• National Institute of Translational Virology and AIDS Research (formarly: National AIDS Research Institute) Sr. Technical Officer
  1994 - 2027

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (10)

• Immuno-Metabolic Reprogramming in Metabolic Syndrome and Its Cardiovascular Complications: An Integrative Bioinformatics Study
  International Journal of Molecular Sciences 2026 DOI: 10.3390/ijms27135923
  +Save
• The Genetic Fingerprint of HIV in the Brain: Insights into Neurocognitive Dysfunction
  Neuroglia 2025 DOI: 10.3390/neuroglia6020023
  +Save
• Disturbances in the gut microbiota potentially associated with metabolic syndrome among patients living with HIV-1 and on antiretroviral therapy at Bafoussam Regional Hospital, Cameroon
  Diabetology & Metabolic Syndrome 2025 DOI: 10.1186/s13098-025-01653-4
  +Save
• The Crosstalk Between HIV-TB Co-Infection and Associated Resistance in the Indian Population
  Venereology 2024 DOI: 10.3390/venereology3040015
  +Save
• Journey of technological advancements in the detection of antimicrobial resistance
  Journal of the Formosan Medical Association 2024 DOI: 10.1016/j.jfma.2023.08.008
  +Save
• Association of Viral and Host Genetic Architecture with the Status of Neurocognitive Disorder in HIV-Infected Individuals
  AIDS Research and Human Retroviruses 2023 DOI: 10.1089/aid.2022.0099
  +Save
• The role of thioredoxin proteins in Mycobacterium tuberculosis probed by proteome-wide target profiling
  Biochemistry and Biophysics Reports 2023 DOI: 10.1016/j.bbrep.2023.101512
  +Save
• The NeuroinflammatoryPotential of HIV-1 NefVariants in Modulating the Gene Expression Profile of Astrocytes
  Cells 2022 DOI: 10.3390/cells11203256
  +Save
• KDR polymorphism (1192G/A, 1719A/T) and modulation of ARV drug-induced hepatotoxicity
  Microbial Pathogenesis 2021 DOI: 10.1016/j.micpath.2021.105243
  +Save
• HIV‐Associated Neurotoxicity: The Interplay of Host and Viral Proteins
  Mediators of Inflammation 2021 DOI: 10.1155/2021/1267041
  +Save